PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för nafenopin. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

11 hits

Bibliografisk träff 2007-12-13

Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators.

Tamasi V, Miller KK, Ripp SL, Vila E, Geoghagen TE, Prough RA.

Mol Pharmacol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1124/mol.107.036780

Bibliografisk träff 2000-12-01

Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.

Hasmall SC, West DA, Olsen K, Roberts RA.

Carcinogenesis · journal article · DOI 10.1093/carcin/21.12.2159

Bibliografisk träff 2000-09-01

A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin.

Cosulich SC, James NH, Needham MR, Newham PP, Bundell KR, Roberts RA.

Carcinogenesis · journal article · DOI 10.1093/carcin/21.9.1757

Bibliografisk träff 2000-08-01

Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferator nafenopin.

Chevalier S, Macdonald N, Tonge R, Rayner S, Rowlinson R, Shaw J, Young J, Davison M, Roberts RA.

Eur J Biochem · journal article · DOI 10.1046/j.1432-1327.2000.01487.x

Bibliografisk träff 2000-07-01

Nafenopin causes protein kinase C-mediated serine phosphorylation and loss of function of connexin 32 protein in rat hepatocytes without aberrant expression or localization.

Elcock FJ, Deag E, Roberts RA, Chipman JK.

Toxicol Sci · journal article · DOI 10.1093/toxsci/56.1.86

Bibliografisk träff 2000-02-01

Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin.

Holden PR, Hasmall SC, James NH, West DR, Brindle RD, Gonzalez FJ, Peters JM, Roberts RA.

Cell Mol Biol (Noisy-le-grand) · journal article

Bibliografisk träff 1999-12-01

Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin.

West DA, James NH, Cosulich SC, Holden PR, Brindle R, Rolfe M, Roberts RA.

Hepatology · journal article · DOI 10.1002/hep.510300612

Bibliografisk träff 1999-07-01

G1-arrested FaO cells re-enter the cell cycle upon stimulation with the rodent non-genotoxic hepatocarcinogen nafenopin.

Chevalier S, Roberts RA.

Carcinogenesis · journal article · DOI 10.1093/carcin/20.7.1209

Bibliografisk träff 1998-12-01

The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro.

Hasmall SC, James NH, Soames AR, Roberts RA.

Arch Toxicol · journal article · DOI 10.1007/s002040050573

Bibliografisk träff 1988-10-01

The use of primary cultures of adult rat hepatocytes to study induction of enzymes and DNA synthesis: effect of nafenopin and electroporation.

Muakkassah-Kelly SF, Bieri F, Waechter F, Bentley P, Stäubli W.

Experientia · research support, non-u.s. gov't; review; journal article · DOI 10.1007/bf01941178

Bibliografisk träff 1980-01-01

Nafenopin.

Författaruppgift saknas

IARC Monogr Eval Carcinog Risk Chem Hum · review; journal article